← All indications
Rhinitis, Allergic
An inflammation of the NASAL MUCOSA triggered by ALLERGENS.
Subtype terms (2)
More specific conditions that are subtypes of Rhinitis, Allergic in the MeSH hierarchy.
- Rhinitis, Allergic, Perennial
64 drugs (37 approved, 27 experimental)
- Rhinitis, Allergic, Seasonal
136 drugs (64 approved, 72 experimental)
Drugs by status
Approved for this indication (25)
- montelukast
- azelastine
- fluticasone
- loratadine
- diphenhydramine
- mometasone
- pemirolast
- prednisone
- betamethasone
- doxylamine
- Ebastine
- flunisolide
- beclomethasone
- bepotastine
- levocetirizine
- clemastine
- chlorpheniramine
- astemizole
- dexbrompheniramine
- antazoline phosphate
- mepyramine
- dexamethasone
- benzathine penicillin
- rotoxamine
- histaglobulin
Phase 4 trials (29)
- rupatadine
- methylprednisolone
- ciclesonide
- theophylline
- capsaicin
- cetirizine
- salmeterol
- fexofenadine
- timothy grass pollen allergen extract
- grazax
- omalizumab
- bilastine
- prazosin
- birch allergen
- house dust mite allergen
- resveratrol
- doxazosin
- triamcinolone
- budesonide
- desloratadine
- carboxymethyl glucan
- emedastine
- sodium chloride
- olopatadine
- pseudoephedrine
- oxymetazoline
- Lactobacillus acidophilus
- water
- bencycloquidium
Phase 3 trials (31)
- phenylephrine
- vitamin d3
- asp-1001
- Bacterial Lysates
- bu-zhong-yi-qi-tang
- zingiber
- dexchlorpheniramine maleate
- sanfujiu
- iloperidone
- lorazepam
- niacin
- succinylcholine
- sweet vernal, orchard, perennial rye, timothy, and kentucky blue grass mixed pollens allergen extract
- pangramin
- qi-tonifying
- regn1908
- short ragweed pollen allergen
- trifolium pratense
- olive allergen
- prednisolone
- lactobacillus rhamnosus
- alk alutard 5-grasses
- regn1909
- regn5713
- regn5714
- regn5715
- t521
- cm310
- magnolia
- yupingfeng
- +1 more
Phase 2 trials (45)
- alutard
- b244
- benjakul
- blx-028914
- dupilumab
- epinastine
- fevipiprant
- ginger
- gsk-1004723
- gsk-256066
- jnj-17166864
- jnj-39220675
- levocabastine
- oc-000459
- osiris
- pf-03654746
- pf-03654764
- azd8848
- qav-680
- sanfu herba
- sparc1203
- vak694
- yu-ping-fung san
- autologous microbiome
- phenol
- actinidia arguta
- gmp rv16 hrv-16
- depigold olea europea
- calcium glycerylphosphate
- qax-576
- +15 more
Phase 1 trials (27)
- ak001
- vitamin e
- acetylcysteine
- cal-263
- ibuprofen
- idelalisib
- esketamine
- ketorolac
- medi-4212
- quilizumab
- nvp-vak694
- pf-04236921
- aluminum hydroxide
- endotoxin
- xmab7195
- umbilical cord mesenchymal stem cells
- cryj2-dna-lamp plasmid vaccine
- cat epidermis allergen
- dog allergen
- fatty acid
- pf-06444753
- pf-06444752
- cct301
- allogeneic mesenchymal stem cells
- lu ag09222
- tqc3564
- ini-2004
Other trials (33)
- maltodextrin
- umifenovir
- canola oil
- cocoa bean
- alpha-lipoic acid
- cannabidiol
- glycerin
- tian jiu
- histamine
- hydrogen
- leukotriene e4
- ganciclovir
- vitamin c
- oseltamivir
- cow milk
- lactose
- sea water
- crizotinib
- bifidobacterium longum
- live attenuated influenza virus vaccine
- coffee
- cd4cd8aa
- methacholine
- spinach
- broccoli sprout
- shea butter
- bacterial allergen extract
- oxygen
- broccoli
- methylhexaneamine
- +3 more
Organizations
Organization Involved with Phase 4 Indications (69)
- Meda
- Takeda
- McNeil
- AstraZeneca
- Pfizer
- Sanofi
- Alcon
- Allergopharma GmbH & Co. KG
- Bayer
- California Allergy and Asthma Medical Group, Inc.
- HAL Allergy
- Handok Pharmaceuticals Co., Ltd.
- Institut für Atemwegsforschung GmbH
- Menarini Group
- ORA, Inc.
- PharmEvo Pvt Ltd
- Sunovion
- Western Sky Medical Research
- Strategic Biosciences
- Hoosier Cancer Research Network
- Indira Gandhi Medical College
- Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy
- Iuliu Hatieganu University of Medicine and Pharmacy
- Katholieke Universiteit Leuven
- Mahidol University
- Medical University of Lodz
- Monash University
- New York City Health and Hospitals Corporation
- Queen's University, Belfast
- Silesian University of Medicine
- +39 more
Organization Involved with Phase 3 Indications (97)
- Abbott
- Actavis
- Actelion
- Sandoz
- Allergy Therapeutics
- Stallergenes
- Perrigo
- Apotex
- Allergan
- Biomedical Development Corporation
- Clinical Research International Limited
- Eurofarma Laboratorios S.A.
- Faes Farma, S.A.
- Hanlim Pharm. Co., Ltd.
- Greer Laboratories
- Inmunotek S.L.
- Leti Pharma GmbH
- Magna Pharmaceuticals, Inc.
- SamA Pharmaceutical Co., Ltd
- Sponsor GmbH
- Teva
- Ahn-Gook Pharmaceuticals Co.,Ltd
- Boehringer Ingelheim
- Chong Kun Dang Pharmaceutical
- Committee on Chinese Medicine and Pharmacy
- GenMont Biotech Incorporation
- Roxall Medizin
- Fondazione Toscana Gabriele Monasterio
- Chang Gung University
- Chulalongkorn University
- +67 more
Organization Involved with Phase 2 Indications (83)
- 3E Therapeutics Corporation
- RespiVert
- Regeneron
- Ligand Pharmaceuticals
- Astellas
- Bausch & Lomb
- Shionogi
- AOBiome LLC
- Anergis
- Antigen Laboratories, Inc.
- Biolipox AB
- CMP Therapeutics Ltd
- Circassia Limited
- Danisco
- Dart NeuroScience, LLC
- Evolutec Group
- Harrison Clinical Research
- Immunomic Therapeutics, Inc.
- Max Zeller Soehne AG
- Nuvo Research Inc.
- Orexo AB
- Oxagen Ltd
- Parexel
- Palau Pharma S.A.
- Rigel Pharmaceuticals
- Yakult Honsha Co., LTD
- Dynavax Technologies Corporation
- Thai Traditional Medical Knowledge Fund
- National Institutes of Health (NIH)
- National Institute of Allergy and Infectious Diseases (NIAID)
- +53 more
Organization Involved with Phase 1 Indications (31)
- Daiichi Sankyo
- Roche
- Gilead Sciences
- Genentech
- MedImmune
- Mylan
- INC Research
- PharmaKing
- Korea Research Foundation
- National Heart, Lung, and Blood Institute (NHLBI)
- Gachon University
- Korea University
- Northwestern University
- Stanford University
- University of Copenhagen
- Xencor
- Procter and Gamble
- Sumitomo Dainippon
- East West Medical Research Institute
- Beijing Institute of Otolaryngology
- University of Texas, Galveston
- University of North Carolina at Chapel Hill
- ICON
- Metronomia Clinical Research GMBH
- Thermo Fisher Scientific
- Synteract, Inc.
- ClinResearch, GmbH
- Prolytic GmbH
- pharm-analyt GmbH
- Consumer Healthcare Products Association
- +1 more
Organization Involved with Other Experimental Indications (30)
- Cosmetique Active International
- Verifomics LLC
- German Research Foundation
- National Institute of Environmental Health Sciences (NIEHS)
- Aarhus University
- Maastricht University
- Tzu Chi University
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Federal University of Uberlandia
- Guangzhou Medical University
- Hong Kong Baptist University
- Hospital Civil Juan I. Menchaca
- Norwegian University of Science and Technology
- University of Guadalajara
- University of Sussex
- University of Bergen
- Creighton University
- Tsinghua University
- University of Vienna
- Government of Mexico
- Innovaderm
- Scripps
- University of Mississippi
- Finnish Institute of Occupational Health
- Lundbeck
- Kyowa Hakko Kogyo
- Shiraz University
- Nanhua University
- Nestle
- Puressentiel